TuHURA Biosciences
HURA
4 hedge funds and large institutions have $650K invested in TuHURA Biosciences in 2019 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 0 increasing their positions, reducing their positions, and 1 closing their positions.
630% more capital invested
Capital invested by funds: $89K → $650K (+$561K)
200% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 1
100% more funds holding
Funds holding: 2 → 4 (+2)
0% more ownership
Funds ownership: 0% → 0.01% (+0%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
+$1.02M |
| 2 |
CH
CVI Holdings
Wilmington,
Delaware
|
+$203K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$35.7K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
-$82K |
HURA Hedge Fund Activity: Q3 2019 in Review
4 of the 4,561 institutional investors tracked by Wall St. Rank reported a position in TuHURA Biosciences (HURA) for Q3 2019, worth a combined $650K — up 630% from $89K a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new HURA positions and 1 closed out — a net gain of 2 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Sabby Management, opening a new position worth an estimated $1.02M. The largest seller was Virtu Financial, exiting entirely with an estimated $82K sold.
- 4 institutional investors held TuHURA Biosciences (HURA) as of Q3 2019, up from 2 in Q2 2019.
- Funds reported $650K of TuHURA Biosciences stock for Q3 2019, up 630% quarter-over-quarter.
- 3 funds opened new TuHURA Biosciences positions in Q3 2019 and 1 closed out, a net change of +2 holders.
- The largest TuHURA Biosciences buyer in Q3 2019 was Sabby Management, an estimated $1.02M added.
- The largest TuHURA Biosciences seller in Q3 2019 was Virtu Financial, an estimated $82K sold.
Based on aggregated 13F filings for Q3 2019.